Latest Beverages News

Hydralyte USA has placed 39.5 million shortfall shares at $0.01 each, boosting total funds raised under its recent Rights Issue to nearly $559,000. The move strengthens the company’s capital position amid ongoing growth efforts.

ALS Limited reported a robust FY25 with 16% revenue growth to AUD 3 billion, underpinned by strong organic expansion and key acquisitions. Despite slight NPAT decline, the company advances its sustainability agenda and invests in global lab upgrades.

Wide Open Agriculture has achieved a breakthrough in lupin protein production, slashing energy consumption by up to 80% and halving processing time in a recent commercial-scale trial. These efficiency gains pave the way for more cost-effective, scalable manufacturing.

Noumi Limited has received Victorian Supreme Court approval for its $43 million class action settlement, closing a significant chapter tied to past financial restatements. The company’s insurer will cover its $11.56 million contribution, while legal costs will impact FY25 results.

The Calmer Co. International Limited has launched its Taki Mai kava tinctures on Amazon USA, marking a strategic expansion into a rapidly growing wellness segment. This move aims to capitalize on the booming US tincture market and strengthen the company’s foothold in natural relaxation products.

The Calmer Co. has secured a major retail milestone by launching its Fiji Kava 50g Instant Kava product across Woolworths supermarkets nationwide, significantly broadening its Australian footprint.

Tasmea Limited has announced a fully franked special dividend of AUD 0.12 per share, payable on 30 June 2025, alongside a Dividend Reinvestment Plan offering a 5% discount on new shares.

BP8 has completed its inaugural shipment of Indonesian seaweed biomass to South Korean manufacturer MSC, Ltd., under a new sales cooperation agreement with PT Kebula Raya Bestari. This initial contract signals BP8’s growing footprint in the global seaweed supply chain.

Top Shelf International Holdings has resolved its long-standing excise debt issue, leading to the dismissal of Australian Taxation Office proceedings against its subsidiary.

Viva Leisure has taken a strategic 33% stake in Gorilla X Labs, aiming to deepen its footprint in the sports nutrition market and enhance member offerings across its platforms.

The Calmer Co. International Limited has significantly expanded the distribution of its flagship kava products in Coles supermarkets, reflecting growing consumer appetite for natural relaxation alternatives to alcohol.

Reef Casino Trust reported stable 2024 financial results with steady distributions, while confidential takeover proposals from two groups are under board review. Operational challenges include rising regulatory costs and inflationary pressures.